<SEC-DOCUMENT>0000721371-24-000005.txt : 20240109
<SEC-HEADER>0000721371-24-000005.hdr.sgml : 20240109
<ACCEPTANCE-DATETIME>20240109064804
ACCESSION NUMBER:		0000721371-24-000005
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20240109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240109
DATE AS OF CHANGE:		20240109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		24521692

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cah-20240109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2024 Workiva--><!--r:4e0206a2-611e-40b8-90ab-a208894b6ead,g:393ecbc2-ef8d-484b-a173-098f33e6efb6,d:66597a92c1a2489ca2e304a5ceb3cb80--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cah-20240109</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000721371</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cah-20240109.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-09</xbrli:startDate><xbrli:endDate>2024-01-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i66597a92c1a2489ca2e304a5ceb3cb80_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 9, 2024</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Cardinal Health, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.751%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Ohio</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-11373</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">31-0958666</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">7000 Cardinal Place</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Dublin</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Ohio</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">43017</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">614</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">757-5000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:31.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common shares (without par value)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CAH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:92.301%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). <br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div><div><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i66597a92c1a2489ca2e304a5ceb3cb80_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.&#160;&#160;&#160;&#160;Results of Operations and Financial Condition. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 9, 2024, Cardinal Health, Inc. (the &#8220;Company&#8221;) issued a news release announcing, among other things, progress on the Company&#8217;s ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure, and an update to its fiscal year 2024 non-GAAP diluted earnings per share outlook. In the news release, the Company also provided an update to its previous expectations for Medical segment profit for the quarter ended December 31, 2023. A copy of this news release is included as Exhibit 99.1 to this report.</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01.&#160;&#160;&#160;&#160;Regulation FD Disclosure. </span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company today will host a conference call beginning at 8:30 a.m. Eastern time during which management will discuss today's announcements. The event will be live-webcast and archived on the Company&#8217;s Investor Relations website. To access the webcast and corresponding slide presentation, visit ir.cardinalhealth.com. No access code is required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:174%">(d) </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:174%">Exhibits</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:174%">.</span></div><div style="margin-top:2pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.725%"><tr><td style="width:1.0%"></td><td style="width:7.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-january92024pre.htm">News release issued by the Company on January 9, 2024</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardinal Health, Inc.<br/>(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: January 9, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Aaron E. Alt</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:  Aaron E. Alt</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:  Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-january92024pre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ie6144358199a48f9b6415f8a38908c12_1"></div><div style="min-height:48.96pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 99.1</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:78px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:14.15pt">Progress achieved on company&#8217;s ongoing business and portfolio review </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">o</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Completed review of growth businesses within the Medical Segment&#58; investing in and further developing at-Home Solutions and OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Logistics as part of the company&#8217;s portfolio for long-term growth and value creation</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">o</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Review of Global Medical Products and Distribution business continues, with focus on driving operational performance through the Medical Improvement Plan</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">o</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Reorganizing leadership structure to continue company&#8217;s simplification efforts, prioritize core operational execution and drive efficiencies, accountability and transparency </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:14.15pt">Updated enterprise operating and segment reporting structure, effective January 1, 2024, to be reflected in company&#8217;s financial reporting beginning third quarter fiscal 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">o</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Providing pro-forma long-term financial targets for updated segment reporting structure</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:14.15pt">Updated fiscal 2024 non-GAAP diluted EPS guidance to high end of $6.75 to $7.00 range</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">o</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Primarily driven by favorability in Interest and Other and Diluted Weighted Average Shares Outstanding, enabled by continued strong cash flow generation and incremental share repurchase during second quarter fiscal 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">o</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Further updates and details to be provided on February 1 during fiscal 2024 Q2 earnings call</font></div><div style="margin-bottom:8pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">DUBLIN, Ohio</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#8211; January 9, 2024 &#8211; Cardinal Health (NYSE&#58;CAH) today announced progress on the company&#8217;s ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure, and an update to its fiscal year 2024 non-GAAP diluted earnings per share (EPS) outlook. These updates build upon the company&#8217;s momentum, focus on long-term value creation, and continued actions to become more streamlined and focused. The company will host an analyst conference call today beginning at 8&#58;30 a.m. E.T. where management will further discuss these announcements.   </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#34;We are excited to demonstrate further progress on how we are driving our company, and healthcare, forward&#8221; said Jason Hollar CEO of Cardinal Health.  &#8220;As we continue down the path of becoming a simplified and more focused company, these actions align with our operational focus on the core of our business, provide increased visibility to key growth areas, and enable greater efficiencies across all our businesses. We continue to prioritize focused execution to best serve our customers and advance our mission as healthcare&#8217;s most trusted partner.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Business and portfolio review update</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">While Cardinal Health&#8217;s business and portfolio review efforts remain active and ongoing, the company has completed a review of its growth businesses within the Medical Segment, at-Home Solutions and OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Logistics, and has determined that investing in and further developing these businesses will drive the most significant long-term shareholder value creation for Cardinal Health.  This conclusion follows the June 2023 announcement that the business review determined that Cardinal Health would retain and invest in its attractive Nuclear and Precision Health Solutions business.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cardinal Health&#8217;s </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">at-Home Solutions</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> business, a $2.6B revenue leading home healthcare medical supplies provider serving people with chronic and serious health conditions in the United States, is well-positioned to continue to accelerate in the coming years with industry trends of care shifting to the home. To support increased demand, the company is investing in network expansion, and today, is announcing plans to build a new distribution center in Texas, with increased capacity, advanced automation and robotics within the facility. This is in addition to the recently opened site in Ohio, and the previously announced expansion in South Carolina set to open this calendar year. </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:48.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cardinal Health&#8217;s </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:700;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> Logistics</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, a $250M revenue leading provider of healthcare logistics, manages over 21 million shipments annually to 22,000 healthcare provider shipping locations across the continuum of care. Powered by its proprietary technology and team&#8217;s deep expertise, the business has a strong operational track record of profitable growth over many years. To sustain the business&#8217; strong performance, the company continues to invest in innovative and technology-driven solutions such as TotalVue&#8482; Insights that enable healthcare supply chain leaders to optimize their transportation and logistics processes and control shipping spend. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cardinal Health&#8217;s review of its Global Medical Products and Distribution business continues, with a focus on executing the Medical Improvement Plan, which remains a critical priority for the enterprise. The company is continuing to drive ongoing initiatives and invest in the business to support customers&#8217; needs and achieve its long-term target. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Operating and segment reporting structure update</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company also announced plans to realign its business to increase its focus on the core and accelerate its growth areas.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Effective January 1, 2024, the company began operating under an updated enterprise operating and segment reporting structure, which includes two reportable segments </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Pharmaceutical and Specialty Solutions </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">and </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Global Medical Products and Distribution (GMPD). </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Separate from these two segments, Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Logistics will be reported as </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Other</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:700;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The Pharmaceutical and Specialty Solutions Segment, previously in the Pharmaceutical Segment, continues under the leadership of Debbie Weitzman. The segment consists of the company&#8217;s largest and most significant businesses, its resilient Pharmaceutical Distribution business and its higher-growth Specialty business, including both downstream Specialty Distribution and upstream Manufacturer Services. Weitzman will continue to report directly to Jason Hollar.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The GMPD segment, previously in the Medical Segment, continues to be led by Steve Mason. The segment consists of the company&#8217;s U.S. and International Products and Distribution businesses, as well as its WaveMark business. Mason will report directly to Jason Hollar and continue to have a pivotal role in driving the success of the Medical Improvement Plan.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Other consists of </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">at-Home Solutions</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:700;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> Logistics</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> from the former Medical Segment, and </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Nuclear and Precision Health Solutions</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> from the former Pharmaceutical Segment. Each of these businesses will continue to operate independently and each of the business leaders, Rob Schlissberg, at-Home Solutions&#59; Emily Gallo, OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Logistics&#59; and Mike Pintek, Nuclear and Precision Health Solutions, will now report directly to Jason Hollar. This updated operating structure is designed to provide greater visibility to the performance of these businesses and allow prioritization of investments to ensure their long-term success.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company plans to report its second quarter fiscal 2024 results on February 1, 2024, according to its former reporting segments and will then report its third quarter fiscal 2024 results and forward on the basis of its updated structure.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Fiscal 24 outlook update </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company updated fiscal year 2024 non-GAAP diluted EPS guidance to the high end of its $6.75 to $7.00 range. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This update is driven by anticipated favorability in fiscal 24 Interest and Other and Diluted Weighted Average Shares Outstanding, due to continued strong cash flow generation, resulting in higher-than-expected cash balances, and the execution of a new $250M accelerated share repurchase program in the second quarter. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company also provided an update to its previous expectations for second quarter Medical segment profit. While utilization trends, including Cardinal Health&#8482; Brand volumes, and inflation mitigation efforts have trended according to the company&#8217;s expectations in the GMPD business, the company now anticipates second quarter Medical segment profit to be generally consistent with first quarter Medical segment profit, due to anticipated non-recurring adjustments in the second quarter. These anticipated non-recurring adjustments do not affect the company&#8217;s progression towards its previously-communicated fiscal 26 targets.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company will provide further updates and details on its fiscal second quarter results and its fiscal 24 guidance during its second quarter earnings call, on February 1, 2024.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:48.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Long-term financial targets</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company reiterated its long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company also provided pro-forma long-term targets for its updated segment reporting structure, and, for information purposes, recast its fiscal 2023 actuals on the same basis</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company&#8217;s previously announced Medical Improvement Plan targeting at least $650M of segment profit by fiscal 26 continues, with elements of that plan to reside in the results of both GMPD and Other.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FY23 Actuals</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Long-term Target</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Businesses</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Pharmaceutical and Specialty Solutions</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revenue&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;$188.8B</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Segment Profit</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;1.87B</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4-6%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Segment Profit CAGR</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Former Pharmaceutical Segment, excluding Nuclear and Precision Health Solutions</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">GMPD</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revenue&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;$12.1B</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Segment Profit&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;$(165)M</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;$300 million</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in Segment Profit by FY26</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former Medical Segment, excluding at-Home Solutions and OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Logistics</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Other</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revenue&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;$4.1B</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Segment Profit&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#126;$410M</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8-10%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Segment Profit CAGR</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">at-Home Solutions, Nuclear and Precision Health Solutions and OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Logistics</font></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company does not provide forward-looking guidance on a GAAP basis as certain financial information, the probable significance of which cannot be determined, is not available and cannot be reasonably estimated. See &#8220;Forward-Looking Non-GAAP Measures&#8221; below for additional explanation.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Analyst Conference Call and Webcasted Investor Events</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company&#160;will hold an analyst conference call, which will be webcast, to discuss today&#8217;s announcements prior to the opening of trading on the New York Stock Exchange beginning at&#160;8&#58;30 a.m.&#160;Eastern.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Additionally, the company plans to present at the 42</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Annual J.P. Morgan Healthcare Conference today beginning at 5&#58;15 p.m. Eastern.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">To access the webcasts and corresponding presentations, visit&#160;</font><font style="color:#0563c1;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Cardinal Health&#8217;s Investor Relations</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Cardinal Health</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Contacts</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Media&#58; Erich Timmerman, erich.timmerman&#64;cardinalhealth.com and 614.757.8231</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Investors&#58; Matt Sims, matt.sims&#64;cardinalhealth.com and 614.553.3661</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Other includes the following three operating segments&#58; at-Home Solutions, Nuclear and Precision Health Solutions and OptiFreight</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Logistics, which are not significant enough individually to require reportable segment disclosure.</font></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:133%">FY24 to FY26 CAGR, as of FY23 baseline. </font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:48.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:7.15pt;font-weight:400;line-height:107%;position:relative;top:-3.85pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Recast FY23 actuals for updated segment reporting structure are considered preliminary and pending a final recast of segment results that is expected to be completed by the company&#8217;s Q3 FY24 earnings release. The sum of the components may reflect rounding adjustments.</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Cautions Concerning Forward-Looking Statements</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as &#34;expect,&#34; &#34;anticipate,&#34; &#34;intend,&#34; &#34;plan,&#34; &#34;believe,&#34; &#8220;will,&#34; &#34;should,&#34; &#34;could,&#34; &#34;would,&#34; &#34;project,&#34; &#34;continue,&#8221; &#34;likely,&#34; and similar expressions, and include statements reflecting future results or guidance, statements of outlook, preliminary recast fiscal 2023 results and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include risks arising from ongoing inflationary pressures, including the risk that our plans to mitigate such effects may not be as successful as we anticipate or that costs could remain elevated&#59; the possibility that our Medical unit goodwill could be further impaired due to additional changes to our long-term financial plan, increases in global interest rates or unfavorable changes in the U.S. statutory tax rate&#59; risks associated with our ongoing review of our operations, portfolio and businesses, including the risk that our management team could become distracted or that the outcome of such review may have unintended consequences&#59; competitive pressures in Cardinal Health's various lines of business, including the risk that customers may reduce purchases made under their contracts with us or terminate or not renew their contracts&#59; the performance of our generics program, including the amount or rate of generic deflation and our ability to offset generic deflation and maintain other financial and strategic benefits through our generic sourcing venture or other components of our generics programs&#59; ongoing risks associated with the distribution of opioids, including the financial impact associated with the settlements with governmental authorities and the risk that challenges to tax deductions for opioid-related losses could adversely impact our financial results&#59; risks arising from the Department of Justice investigation which we believe concerns our anti-diversion program and risks associated with the injunctive relief requirements under the national settlement, including the risk that we may incur higher costs or operational challenges in the implementation and maintenance of the required changes&#59; risks associated with the manufacture and sourcing of certain products, including risks related to our ability and the ability of third-party</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:13.5pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">manufacturers to import or export certain products or component parts and to comply with applicable regulations&#59; our ability to manage uncertainties associated with the pricing of branded pharmaceuticals&#59; uncertainties related to the timing, magnitude and profit impact of the distribution of recently commercially available COVID-19 vaccines&#59; risks associated with business process initiatives, such as the Medical Improvement Plan, including the possibility that they could fail to achieve the intended results&#59; and the risk that we may not realize the anticipated benefits related to our updated operating and segment reporting structure. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management&#8217;s views as of January 9, 2024. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any commitment, expectation, initiative or plan in this news release can or will be achieved or completed.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward Looking Non-GAAP Measures</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In this news release, the company presents certain forward-looking non-GAAP metrics. The company does not provide outlook on a GAAP basis because the items that the company excludes from GAAP to calculate the comparable non-GAAP measure can be dependent on future events that are less capable of being controlled or reliably predicted by management and are not part of the company&#8217;s routine operating activities. Additionally, management does not forecast many of the excluded items for internal use and therefore cannot create or rely on outlook done on a GAAP basis.</font></div><div style="margin-bottom:8pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The occurrence, timing and amount of any of the items excluded from GAAP to calculate non-GAAP could significantly impact the company&#8217;s fiscal 2024 GAAP results. Over the past five fiscal years, the excluded items have impacted the company&#8217;s EPS from $0.75 to $18.06, which includes a $17.54 charge related to the opioid litigation the company recognized in fiscal 2020.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Definitions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP net earnings attributable to Cardinal Health, Inc.&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;ne</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">t earnings</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;attributable to Cardinal Health, Inc. excluding (1) LIFO charges&#47;(credits), (2) state opioid assessment related to prior fiscal years, (3) shareholder cooperation agreement costs, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)&#47;loss on disposal of assets, net, (7) litigation (recoveries)&#47;charges, net and (8) loss on early extinguishment of debt.</font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:48.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP diluted earnings per share attributable to Cardinal Health, Inc.&#58;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;non-GAAP net earnings attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding.</font></div><div style="height:42.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cah-20240109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:4e0206a2-611e-40b8-90ab-a208894b6ead,g:393ecbc2-ef8d-484b-a173-098f33e6efb6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cah="http://www.cardinal.com/20240109" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20240109">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20240109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20240109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cah-20240109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:4e0206a2-611e-40b8-90ab-a208894b6ead,g:393ecbc2-ef8d-484b-a173-098f33e6efb6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_4e1f2afa-9a45-4f44-8258-91d9c956743e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_03cb13e1-6e39-46f0-bc81-3567ec0809c8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5a4ad030-42b2-402f-9b6c-9d146dcc94fd_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4f78648b-0b95-4e84-a853-056e0b07ddce_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_24bc64e9-0ac3-438b-b58c-fcee8873d7f3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_dde13847-2dcd-4f78-afae-71398f54936d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_93b2bf22-79fe-43bd-bbac-5d87e5b41b6c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_989b4dda-a4a0-4495-b348-b215c7f62acb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e5a600d1-57f1-4779-8298-3dfc4cda1d53_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2802e26d-8027-4f2a-a0cb-4b2d62e760e4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4fabf336-8b04-4562-9ed0-46b6c6f9570b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_917c31c9-1f7e-422d-8013-60fd162c335a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_865fdbc4-cbef-4180-a7f7-4563adc2d150_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c7507628-5201-480d-99c4-05671caa9121_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_53ee1529-3437-43c4-8560-7d09a4854281_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_19ad42a7-4dc6-41b1-8bd3-4669f2b5cb52_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_dd561953-89cd-4179-8ab3-170dcae5061a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_985ae3a0-cbbc-4cfe-9d94-b1e8258ad6de_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_605bc811-2b4c-4133-8c8a-3bcef72c8850_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a3161bb0-7d4c-4ba7-8393-036a15731f09_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e1557f8c-05a5-4f93-956e-803e9c0df9d8_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a64e32b5-af49-4583-8ec9-cc4ec598408a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a2325018-29dd-4eea-bda5-30fc2a936dd8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cah-20240109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:4e0206a2-611e-40b8-90ab-a208894b6ead,g:393ecbc2-ef8d-484b-a173-098f33e6efb6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:type="simple" xlink:href="cah-20240109.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1c8a05d3-9509-400a-b825-a177bddeefe2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_DocumentType_1c8a05d3-9509-400a-b825-a177bddeefe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c6371901-78a7-4603-9153-2c9b9cf394c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_DocumentPeriodEndDate_c6371901-78a7-4603-9153-2c9b9cf394c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3d4175dc-7e24-4d42-99de-3640ae8ce617" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityRegistrantName_3d4175dc-7e24-4d42-99de-3640ae8ce617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4338fe22-ca12-4869-9ae7-b459011db725" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4338fe22-ca12-4869-9ae7-b459011db725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f07399ef-1f23-4609-885d-1d04e871a3b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityFileNumber_f07399ef-1f23-4609-885d-1d04e871a3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ff6fb65e-5679-4354-90c1-8a4405da2c22" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityTaxIdentificationNumber_ff6fb65e-5679-4354-90c1-8a4405da2c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_cf4246dc-f8ca-4c41-bee6-f44313577459" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityAddressAddressLine1_cf4246dc-f8ca-4c41-bee6-f44313577459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fe6de299-7773-4481-91c3-63b48d16623f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityAddressCityOrTown_fe6de299-7773-4481-91c3-63b48d16623f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_eff97e9d-ac74-478c-b76d-84f225d64af7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityAddressStateOrProvince_eff97e9d-ac74-478c-b76d-84f225d64af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_288239fa-ad43-49ec-8ea9-2656561642f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityAddressPostalZipCode_288239fa-ad43-49ec-8ea9-2656561642f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5abe95d0-4c74-466c-8cdf-a5221de86566" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_CityAreaCode_5abe95d0-4c74-466c-8cdf-a5221de86566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_df40612d-ac2f-43d1-817b-8daed6d42ebe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_LocalPhoneNumber_df40612d-ac2f-43d1-817b-8daed6d42ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_60b8bbc6-6f73-4b8d-9db5-4fd5361114fa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_WrittenCommunications_60b8bbc6-6f73-4b8d-9db5-4fd5361114fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_74bb459e-bc2b-4ba8-b949-5dbb80384837" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_SolicitingMaterial_74bb459e-bc2b-4ba8-b949-5dbb80384837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4710f579-d813-42dd-a6f9-22c2b9843d7b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_PreCommencementTenderOffer_4710f579-d813-42dd-a6f9-22c2b9843d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ba16b9bf-bb22-4f93-9aec-ebac6b0bfaff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ba16b9bf-bb22-4f93-9aec-ebac6b0bfaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_34f87552-b38d-478a-92a0-6afb3871de98" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_Security12bTitle_34f87552-b38d-478a-92a0-6afb3871de98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3017dea4-9c2f-45c6-a23d-e0ff24a5181e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_TradingSymbol_3017dea4-9c2f-45c6-a23d-e0ff24a5181e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_80e7ecb7-b204-4874-91a4-1b82ff0aaaf0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_SecurityExchangeName_80e7ecb7-b204-4874-91a4-1b82ff0aaaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6937bc85-e02e-4d80-b77b-306b2ce423f7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityEmergingGrowthCompany_6937bc85-e02e-4d80-b77b-306b2ce423f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1a93bb27-f045-4dae-a628-058a66d1ccc5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_EntityCentralIndexKey_1a93bb27-f045-4dae-a628-058a66d1ccc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dfde9528-6917-4917-89d0-a8f5871310ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_be93a1d2-63af-43ef-a062-e4cc9d9bb6bd" xlink:to="loc_dei_AmendmentFlag_dfde9528-6917-4917-89d0-a8f5871310ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !M 0<# 2(  A$! Q$!_\0
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M8^P)K15(-V3.2>#KPCSS@TN[3L:E%%%6<P4444 %%%% !1110 4444 %%%%
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M47^.,6^Y\_\ P]^/WQ-\0V(M_A9^S#)X,T>3[EYXPU&T\-QI[FSMTFG(_P"
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M3XFW'BKXV>.[[4[S4O&5O<SW=W#I_P!J_<Q02W(WK*[3+&'(R@B;;C((PO\
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MBW\2/8^(;K4I)-2LS!;JT)CF)W+L/*XZ5\S_ /!.KP3^W'_P5H_9&UB?P_\
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M /285R__  0/7P%'_P %^?B;'\+8H(?AQ!I&OP^&UAD>2+["EW:K$R,Y+,I
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M1?\ TN-2_L12JO\ P6O_ &SHRRB0V'@]PA/S%?L$O./3WI@>,^,OV?\ Q/\
MM)?\'!?QC\.Z/\1O%/PV\/CX<:)<:_=>&94MM8U&)7 BMH;EE8VZER6=T&XA
M H(#$UZ1\'6\>_\ !/;_ (*I>!?@I+\3O&_Q0^%GQI\-ZGJ6F0^,KX:EJOAK
M4-/59)/+NB [P2(WW6Z%O;)T?@!_RL3?'_\ [)=H'_HX5/\ MA?\IX/V/_\
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M5?"7]I#]H"V^*.J0^+O#_CF.WAM+O4_#7B2\T9]6@A8-'#="!U$R+M PPZ
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,ON^B:* "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140407819816416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jan. 09, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  09,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cah-20240109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cah-20240109.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2024-01-09</startDate>
            <endDate>2024-01-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000721371</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-01-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-11373</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">614</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">757-5000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    (  $V*5B7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @  38I6!E%%?4W 0
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M)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04    "  !-BE8)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @  38I6&60>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    (  $V*5A4__)&[@   "L"   1
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M96QS+RYR96QS4$L! A0#%     @  38I6!E%%?4W 0  )P(   \
M     ( !0Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  $V*5@D'INB
MK0   /@!   :              "  :<1  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    (  $V*5AED'F2&0$  ,\#   3
M  "  8P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  -83
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cah-20240109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cah-20240109.htm">cah-20240109.htm</File>
    <File>cah-20240109.xsd</File>
    <File>cah-20240109_lab.xml</File>
    <File>cah-20240109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cah-20240109.htm": {
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20240109",
   "dts": {
    "inline": {
     "local": [
      "cah-20240109.htm"
     ]
    },
    "schema": {
     "local": [
      "cah-20240109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20240109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20240109_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cardinal.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cah-20240109.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cah-20240109.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000721371-24-000005-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-24-000005-xbrl.zip
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M!HWY( E"D"F3E9Q6V3P4L9#!SY;^<]@'GHT^'?%X$OQR(CF-R1F54MS^<J
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M<:^<2"I%^Y?S%'12=" U _5T>%R 1D*U],P(X?'0_FA)X9M"1L2+^-,=L.[
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MW/]\^V+]2;I\]OC;%_\'4$L#!!0    (  $V*5CR\%9]K 8  .DP   4
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MR)A<XY1.,Y7(0E^HL\+,3MO[G>,&H3V4N<(1D*]Z1X-OP5;-A"1^,V,-4(\
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M;I0U@ZXRRC:FY%BW'71?+>DVK[I *00J+JGL2(YI@-8 ^(I^#[S )$$!ASO
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M1[PKRP!AY@]CN"P%1*Q!&A?L1H<;WW> WE#K.1PW4=/2SE_-]QTB"9&;_[Y
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M9S/;K ']@82S7^#=7]H3OSU06]2:O+OVZJ8ZCA.UB06NE]>T!D:M9B(!TNT
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MZNVIV+F5%")-W-'UX*RQ.R#,G2!=H1RN23=406//X;RQ-LR_]@6QE2]: C/
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M)EW*T?U\UAS*Z'Q,L>&V)?,1_7/VS9) 383%TA4W:2=3A-%E7<J1"$#)$/0
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MT,1S^,^DF":/_A]02P$"% ,4    "  !-BE8-;3P=0,0  "_=0  $
M        @ $     8V%H+3(P,C0P,3 Y+FAT;5!+ 0(4 Q0    (  $V*5CT
M($^2;P(  'H'   0              "  3$0  !C86@M,C R-# Q,#DN>'-D
M4$L! A0#%     @  38I6%[0?=YJ"@  2UX  !0              ( !SA(
M &-A:"TR,#(T,#$P.5]L86(N>&UL4$L! A0#%     @  38I6/+P5GVL!@
MZ3   !0              ( !:AT  &-A:"TR,#(T,#$P.5]P<F4N>&UL4$L!
M A0#%     @  38I6+ BQTOY'0  %[,  !X              ( !2"0  &5X
M:&EB:70Y.3$M:F%N=6%R>3DR,#(T<')E+FAT;5!+!08     !0 % $P!  !]
%0@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
